Karyopharm Therapeutics | KPTI - 流動負債

株価
8.00
毎日の変更
-0.16 -1.96%
毎月
-8.57%
毎年
86.48%
Q2 予測
7.78




流動負債 変化する 日付
AbbVie USD 43.29B 3.9B 2025-12
Abbott USD 16.5B 1.91B 2025-12
Amgen USD 25.49B 3.7B 2025-12
AstraZeneca USD 30.62B 3.44B 2025-12
BioCryst Pharmaceuticals USD 196.07M 5.83M 2025-12
Bristol-Myers Squibb USD 28.14B 608M 2025-09
Eli Lilly USD 35.23B 4.91B 2025-12
Enanta Pharmaceuticals USD 44.73M 3.83M 2025-12
GlaxoSmithKline GBP 21.39B 57M 2025-12
Incyte USD 1.52B 176.44M 2025-12
J&J USD 54.13B 3.26B 2025-12
Karyopharm Therapeutics USD 92.06M 4.9M 2025-12
MacroGenics USD 43.11M 1.36M 2025-12
Merck USD 28.63B 2.59B 2025-09
Nektar Therapeutics USD 53.54M 12.8M 2025-12
Novartis USD 27.28B 4.72B 2025-12
Novartis USD 27.28B 4.72B 2025-12
Pfizer USD 36.6B 1.13B 2025-09
Regeneron Pharmaceuticals USD 4.37B 56.7M 2025-12
Roche Holding CHF 28B 421M 2025-12
Sangamo BioSciences USD 47.66M 1.9M 2025-06
Takeda JPY 2.61T 470.53B 2025-12
Tectonic Therapeutic USD 9.67M 293K 2025-12
TG Therapeutics USD 153.76M 3.05M 2025-12
Ultragenyx Pharmaceutical USD 340.02M 46.78M 2025-09
Xencor USD 95.91M 9.42M 2025-12